Tag results:

acute lung injury

Knockdown of Circ_0001679 Alleviates Lipopolysaccharide-Induced MLE-12 Lung Cell Injury by Regulating the miR-338-3p/ Mitogen-Activated Protein Kinase 1 Axis

[Bioengineered] Researchers indicated that circ_0001679/miR-338-3p/MAPK1 axis may play an important role in the pathogenesis of acute lung injury.

Interferon-γ Promotes Monocyte-Mediated Lung Injury during Influenza Infection

[Cell Reports] The authors identified an interferon-γ-regulated subset of monocytes, CCR2+ monocytes, as a driver of lung damage during influenza A virus infection.

Mesenchymal Stem Cell-Based Treatments for COVID-19: Status and Future Perspectives for Clinical Applications

[Cellular and Molecular Life Sciences] Investigators describe the origins, pathogenesis, and clinical features of COVID-19 and the potential uses of MSCs in therapeutic treatments for severe acute respiratory syndrome coronavirus 2-infected patients.

Knockdown of circRNA Paralemmin 2 Ameliorates Lipopolysaccharide-Induced Murine Lung Epithelial Cell Injury by Sponging miR-330-5p to Reduce ROCK2 Expression

[Immunological investigations] CircRNA paralemmin 2 modulated lipopolysaccharide-caused murine lung epithelial cell injury by the microRNA-330-5p (miR-330-5p)/rho-associated coiled-coil containing protein kinase 2 (ROCK2) pathway, providing a therapeutic target for acute lung injury.

Irreversibility of Pulmonary Fibrosis

[Aging and Disease] The authors discuss the underlying pathogenesis of irreversible pulmonary fibrosis as well as preclinical disease models, and also suggest directions for future studies.

Cathepsin S Contributes to Lung Inflammation in Acute Respiratory Distress Syndrome

[American Journal of Respiratory and Critical Care Medicine] Human and mouse model bronchoalveolar lavage fluid samples were analyzed for the presence and activity of cathepsin S and its endogenous inhibitors.

Popular